Hetero's Tocira gets Emergency Use Authorization from DCGI for the generic version of Tocilizumab in India.
<p>
Hyderabad-based pharma company Hetero said on Monday it has received emergency use approval from the Indian health authorities to make a generic version of Swiss giant Roche Holding AG&#39;s drug Tocilizumab used for treating COVID-19 patients.</p>
<p>
Hetero is likely to make the cheaper version of Tocilizumab available in Indian market by the end of the month under the local brand name Tocira. The drug will be produced at the company&rsquo;s plant in Hyderabad.</p>
<p>
Tocilizumab has been in high demand due to the surge in COVID-19 cases and there is a shortage of the drug worldwide.</p>
<p>
Roche&#39;s blockbuster arthritis drug, tocilizumab, cuts the risk of death among patients hospitalised with severe COVID-19. It also cuts the recovery time and reduces the need for mechanical ventilation.</p>
<p>
Hetero, also makes medicines such as remdesivir and favipiravir used for treating COVID-19 patients.</p>
Iranian Foreign Minister, Seyed Abbas Araghchi, said on Saturday that President Donald Trump should put…
The national capital is hosting ten representatives from the American state of Montana, who are…
An earthquake of magnitude 6.0 struck the Philippines in the early hours of Saturday, as…
NATO's recent decision to ramp up military spending will not significantly impact Russia's security, Foreign…
India has imposed anti-dumping duties on imports of Plastic Processing Machines from China and Taiwan,…
The Human Rights Desk of the Department of Information and International Relations for the Central…
